Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research based on extensive ...
Biotechnology
May 5, 2020
0
8
A team led by Professor Patrick Labonté at the Institut National de la Recherche Scientifique (INRS) in Montreal, Canada, has identified the role of a key process in the replication cycle of the hepatitis D virus, an infection ...
Cell & Microbiology
Dec 20, 2019
0
4
Small differences in a liver cell protein have significant impacts on hepatitis C virus replication in mice and humans, findings that could facilitate the development of a mouse model of the infection. The report, led by ...
Molecular & Computational biology
May 10, 2019
0
42
Large swaths of DNA and its lesser-known cousin RNA are dotted by chemical tags that act like Post-It notes, providing additional instructions to the underlying genetic code.
Cell & Microbiology
Oct 20, 2016
0
10
Viral infection is one of the leading medical challenges of the 21st Century, ranging from the Hepatitis C Virus (HCV) epidemic affecting 3% of the global population, to recent outbreaks of West Nile, Zika, and Ebola viruses.
Biochemistry
Oct 11, 2016
0
2
Harvard Medical School scientists have found a compound that in laboratory dishes blocks the dengue virus in two ways, raising hopes for a future drug whose dual activity could suppress the otherwise likely emergence of drug ...
Cell & Microbiology
Apr 22, 2016
0
429
Viruses are molecular thieves that take from their hosts under the cloak of darkness. But now a Virginia Tech scientist has found a way to not only track viral hijackers, but also potentially stop them from replicating.
Cell & Microbiology
Feb 18, 2016
1
15
NS3 is an enzyme specific to the hepatitis C virus. If developed, a drug capable of recognizing and selectively attacking it could fight the disease without side effects for the body. However, to be able to develop one we ...
Biochemistry
Sep 10, 2015
0
24
New research from the University of Southampton has identified how changes in the cell membrane play a pivotal role in how the Hepatitis C virus replicates.
Biochemistry
May 19, 2015
0
70
Emory scientists have adapted an antiviral enzyme from bacteria called Cas9 into an instrument for inhibiting hepatitis C virus in human cells.
Cell & Microbiology
Apr 28, 2015
0
44
